Antipsychotics may accelerate the development of type 2 diabetes mellitus, according to a new study.
Diabetes Type 2
Fasting sounds like a bad idea for anyone with type 2 diabetes and especially bad for someone taking antihyperglycemic drugs. But, is it really?
The ability to monitor glucose levels quite literally with the blink of an eye has gotten one step closer to clinical application. Get a quick review.
The influenza virus can be debilitating for your diabetes patients for many reasons. Here are some tips to help you help them stay safe this year.
Increased risk for CV events and severe hypoglycemia in T2D patients treated with β-blockers seems reason enough to rethink this Rx.
One theory is that metformin taken during insulin treatment impacts energy intake and so supports weight loss. A quick look at a new study suggests something else.
Take our 6-question True or False spot-check quiz on ADA vaccine recommendations.
Is GLP-1 part of the answer to why cardiac mortality tends to be higher in diabetes patients treated with intensive glycemic control?
Five studies on the impact of diabetes drugs on CV outcomes get the editors' nod for the most promising results in 2017 diabetes research. Find out which 5!
Significant reductions were seen in MACE, renal disease progression in patients with high CV risk taking canagliflozin.